These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30793376)

  • 21. Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy.
    Nieto-Ríos JF; Serna-Higuita LM; Builes-Rodriguez SA; Restrepo-Correa RC; Aristizabal-Alzate A; Ocampo-Kohn C; Serna-Campuzano A; Cardona-Díaz N; Giraldo-Ramirez ND; Zuluaga-Valencia GA
    Colomb Med (Cali); 2016 Mar; 47(1):51-8. PubMed ID: 27226665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.
    Molander P; Färkkilä M; Kemppainen H; Blomster T; Jussila A; Mustonen H; Sipponen T
    Scand J Gastroenterol; 2017 Mar; 52(3):284-290. PubMed ID: 27806638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of inflammatory bowel disease patients treated with TNF-α inhibitors: two-year follow-up.
    Lehtola E; Haapamäki J; Färkkilä MA
    Scand J Gastroenterol; 2016 Dec; 51(12):1476-1481. PubMed ID: 27686143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
    Oh IH; Lee CH; Kim GH; Kang CM; Park JS
    Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
    Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory Bowel Diseases in Renal Transplantat Recipients: A Case Series and Review of the Literature.
    Vrus J; Jukić NB
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2022 Apr; 43(1):57-63. PubMed ID: 35451295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.
    Abitbol Y; Laharie D; Cosnes J; Allez M; Nancey S; Amiot A; Aubourg A; Fumery M; Altwegg R; Michetti P; Chanteloup E; Seksik P; Baudry C; Flamant M; Bouguen G; Stefanescu C; Bourrier A; Bommelaer G; Dib N; Bigard MA; Viennot S; Hébuterne X; Gornet JM; Marteau P; Bouhnik Y; Abitbol V; Nahon S;
    J Crohns Colitis; 2016 Oct; 10(10):1179-85. PubMed ID: 27402916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of donor kidney function and donor age on poor outcome of living-unrelated kidney transplantation (KT) in comparison with living-related KT.
    Park KS; Shin JH; Jang HR; Lee JE; Huh WS; Kim YG; Oh HY; Kim DJ
    Clin Transplant; 2014 Sep; 28(9):953-60. PubMed ID: 24861232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for asymptomatic bacteruria at one month after adult kidney transplantation: Clinical factors and implications.
    Goh YSB; Deng Z; Cheong PSC; Raman L; Goh THA; Vathsala A; Tiong HY
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28295630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo Inflammatory Bowel Disease in Kidney Transplant Recipients: A Single-Center Case Series Study.
    Ogata M; Kato M; Miyauchi T; Murata-Hasegawa M; Sakurai Y; Shinoda K; Yamazaki H; Shibagaki Y; Yazawa M
    Inflamm Intest Dis; 2024; 9(1):96-102. PubMed ID: 38628544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study.
    Kristensen SL; Ahlehoff O; Lindhardsen J; Erichsen R; Lamberts M; Khalid U; Nielsen OH; Torp-Pedersen C; Gislason GH; Hansen PR
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):857-62. PubMed ID: 25316773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
    Abraham NS; Richardson P; Castillo D; Kane SV
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for 90-day readmission in veterans with inflammatory bowel disease-Does post-discharge follow-up matter?
    Malhotra A; Phatharacharukul P; Thongprayoon C
    Mil Med Res; 2018 Feb; 5(1):5. PubMed ID: 29502532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.
    Ko MK; Ng SC; Mak LY; Li MK; Lo FH; Ng CK; Lao WC; Tsang S; Chan KH; Hui YT; Shan EH; Loo CK; Hui AJ; To WP; Hung IF; Leung WK
    J Dig Dis; 2016 Sep; 17(9):610-617. PubMed ID: 27533786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Characteristics of Kidney Transplant Recipients According to 1-Year Chronic Kidney Disease Stage 3a and Stage 3b Graft Function.
    Baek CH; Kim H; Yang WS; Han DJ; Park SK
    Artif Organs; 2017 Apr; 41(4):381-391. PubMed ID: 27653963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical course of IgA nephropathy after kidney transplantation and its management.
    Lionaki S; Panagiotellis K; Melexopoulou C; Boletis JN
    Transplant Rev (Orlando); 2017 Apr; 31(2):106-114. PubMed ID: 28209246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease.
    Tse CS; Loftus EV; Raffals LE; Gossard AA; Lightner AL
    Aliment Pharmacol Ther; 2018 Jul; 48(2):190-195. PubMed ID: 29808485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of impact of hepatitis C virus infection on graft survival after kidney transplantation--a Portuguese single-center experience.
    Magalhães-Costa P; Lebre L; Machado D; Chagas C
    Transplant Proc; 2015 May; 47(4):926-32. PubMed ID: 26036487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.